Cite
HARVARD Citation
Denkinger, C. et al. (n.d.). 1142. Plasma with high titers of anti-SARS-Cov2 antibodies improves outcome of COVID-19 in patients with hematological malignancy and cancer in a randomized controlled trial. Open forum infectious diseases. p. . [Online].